Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 71, Issue 3, Pages 214-221Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2008.12.006
Keywords
Cancer; Chemotherapy; Nausea; Vomiting; Elderly; Antiemetics
Categories
Ask authors/readers for more resources
There is a global and continuing increase in the population of elderly people. This is particularly true among patients with cancer including those receiving chemotherapy. There are no guidelines that in particular address prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in the elderly. Elderly have a potential decreased risk of CINV due to the fact that they are often treated with less emetic chemotherapy and due to the fact that high age is protective. On the other hand, elderly have an increased risk of toxicity from antiemetics due to age-related decrease in organ function, use of poly-pharmacy with increased risk of drug-drug interactions and due to co-morbidity. Compliance needs to be carefully evaluated, particularly in patients with high risk of non-comphance, such as elderly with dementia and impaired vision. (c) 2009 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available